Doxorubicin Hydrochloride Liposome and Bortezomib in Treating Patients With Refractory Hematologic Cancer or Malignant Solid Tumor or Metastatic Breast Cancer

Clinical trial NCT00237627 · COMPLETED

Trial details

NCT number: NCT00237627
Sponsor: UNC Lineberger Comprehensive Cancer Center
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Breast Cancer Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Ovarian Cancer Unspecified Adult Solid Tumor, Protocol Specific

Start date: 2001-05-01
Primary completion: 2006-12-01
Enrollment: 107

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.